Anti-NMNAT1 antibodies are used in the immunodetection of the protein nicotinamide nucleotide adenylyltransferase 1. In humans, the canonical protein has a reported length of 279 amino acid residues and a mass of 31.9 kDa. Its subcellular localization is in the nucleus. It is reported to be widely expressed with highest levels in skeletal muscle, heart and kidney. A member of the Eukaryotic NMN adenylyltransferase protein family, NMNAT1 is known to catalyze the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP. Synonyms for this target antigen include NMN adenylyltransferase 1, NMN/NaMN adenylyltransferase 1, NaMN adenylyltransferase 1, and nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1. NMNAT1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of NMNAT1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunohistochemistry is also a common application.